Development and validation of a risk prediction model for premenopausal breast cancer in 19 cohorts.
Saved in:
| Title: | Development and validation of a risk prediction model for premenopausal breast cancer in 19 cohorts. |
|---|---|
| Authors: | Brantley KD; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA. kbrantley@g.harvard.edu.; Department of Medical Oncology, Dana-Farber Cancer Institute, 375 Longwood Ave LW737, Boston, MA, 02115, USA. kbrantley@g.harvard.edu., Jones ME; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK., Tamimi RM; Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA., Rosner BA; Department of Medicine, Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA., Kraft P; Division of Cancer Epidemiology and Genetics, Transdivisional Research Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Nichols HB; University of North Carolina, Gillings School of Global Public Health, Chapel Hill, NC, USA., O'Brien KM; Epidemiology Branch, National Institute of Environmental Health Sciences, Research Triangle Park, Durham, NC, USA., Adami HO; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.; Clinical Effectiveness Research Group, Institute of Health and Society, University of Oslo, Oslo, Norway., Aizpurua A; Ministry of Health of the Basque Government, Sub Directorate for Public Health and Addictions of Gipuzkoa, San Sebastian, Spain.; Biogipuzkoa Health Research Institute, Epidemiology of Chronic and Communicable Diseases Group, San Sebastián, Spain., Berrington de González A; Clinical Cancer Epidemiology, Institute of Cancer Research, Sutton, London, UK., Blot WJ; Department of Medicine, Division of Epidemiology, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA., Braaten T; Department of Community Medicine, UiT The Arctic University of Norway, Tromsø, Norway., Chen Y; Department of Population Health, Division of Epidemiology, NYU Grossman School of Medicine, New York, NY, USA., DeHart JC; School of Community and Global Health, Claremont Graduate University, Claremont, CA, US., Dossus L; Nutrition and Metabolism Branch, International Agency for Research On Cancer, Lyon, France., Elias S; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands., Fortner RT; Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany.; Department of Research, Cancer Registry of Norway, Norwegian Institute of Public Health, Oslo, Norway., Garcia-Closas M; Cancer Epidemiology and Prevention Unit, Institute of Cancer Research, Sutton, London, UK., Gram IT; Department of Community Medicine, UiT The Arctic University of Norway, Tromsø, Norway., Håkansson N; Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden., Hankinson SE; Department of Biostatistics and Epidemiology, School of Public Health and Health Sciences, University of Massachusetts, Amherst, MA, USA., Kitahara CM; Division of Cancer Epidemiology and Genetics, Radiation Epidemiology Branch, National Cancer Institute, Bethesda, MD, USA., Koh WP; Healthy Longevity Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Linet MS; Division of Cancer Epidemiology and Genetics, Radiation Epidemiology Branch, National Cancer Institute, Bethesda, MD, USA., MacInnis RJ; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, VIC, Australia.; Centre for Epidemiology and Biostatics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC, Australia., Masala G; Clinical Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Florence, Italy., Mellemkjær L; Danish Cancer Institute, Copenhagen, Denmark., Milne RL; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, VIC, Australia.; Centre for Epidemiology and Biostatics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC, Australia.; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia., Muller DC; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK., Park HL; Department of Pathology and Laboratory Medicine, Department of Epidemiology, UC Irvine School of Medicine, Irvine, CA, USA., Ruddy KJ; Department of Oncology, Mayo Clinic, Rochester, MN, USA., Sandin S; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden., Shu XO; Department of Medicine, Institute for Medicine and Public Health, Division of Epidemiology, Vanderbilt Genetics Institute, Vanderbilt University Medical Center, Nashville, TN, USA., Tin Tin S; Cancer Epidemiology Unit, Oxford Population Health, University of Oxford, Oxford, UK., Truong T; Université Paris-Saclay, UVSQ, Inserm, Gustave Roussy, CESP, 94805, Villejuif, France., Vachon CM; Department of Quantitative Health Sciences, Division of Epidemiology, Mayo Clinic, Rochester, MN, USA., Vatten LJ; Department of Public Health and Nursing, Faculty of Medicine, Norwegian, University of Science and Technology, Trondheim, Norway., Visvanathan K; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA., Weiderpass E; Cancer, World Health Organization, International Agency for Research On , Lyon, France., Willett W; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.; Department of Medicine, Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, MA, USA., Wolk A; Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden., Yuan JM; Cancer Epidemiology and Prevention Program, UPMC Hillman Cancer Center, Pittsburgh, PA, USA.; Department of Epidemiology, University of Pittsburgh School of Public Health, Pittsburgh, PA, USA., Zheng W; Department of Medicine, Institute for Medicine and Public Health, Division of Epidemiology, Vanderbilt Genetics Institute, Vanderbilt University Medical Center, Nashville, TN, USA., Sandler DP; Epidemiology Branch, National Institute of Environmental Health Sciences, Research Triangle Park, Durham, NC, USA., Schoemaker MJ; Real World Solutions, IQVIA, Amsterdam, Netherlands., Swerdlow AJ; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.; Division of Breast Cancer Research, The Institute of Cancer Research, London, UK., Eliassen AH; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.; Department of Medicine, Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, MA, USA. |
| Source: | Breast cancer research : BCR [Breast Cancer Res] 2025 May 01; Vol. 27 (1), pp. 67. Date of Electronic Publication: 2025 May 01. |
| Publication Type: | Journal Article; Validation Study |
| Journal Info: | Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 100927353 Publication Model: Electronic Cited Medium: Internet ISSN: 1465-542X (Electronic) Linking ISSN: 14655411 NLM ISO Abbreviation: Breast Cancer Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
